Research programme: osteoporosis therapies - Phosphagenics

Drug Profile

Research programme: osteoporosis therapies - Phosphagenics

Alternative Names: Parathyroid hormone fragments - Phosphagenics; TPM 01/PTH

Latest Information Update: 23 Feb 2010

Price : $50

At a glance

  • Originator Phosphagenics
  • Class Peptide hormones
  • Mechanism of Action Parathyroid hormone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Osteoporosis

Most Recent Events

  • 24 Aug 2005 Preclinical trials in Osteoporosis in Australia (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top